Lifecare AS (DE:LFC) has released an update.
Lifecare ASA, a medical sensor company, has announced the successful subscription of 65,599 shares by Hannibal Invest AS at NOK 1,52442 each, as part of its Rights Issue. This transaction follows Hannibal Invest’s underwriting commitment and involves an entity associated with board member Hans Hekland. Lifecare is focused on advancing Continuous Glucose Monitoring systems using its proprietary ‘Sencell’ technology.
For further insights into DE:LFC stock, check out TipRanks’ Stock Analysis page.
